Ingevity Corp Files DEFA14A Proxy Statement
Ticker: NGVT · Form: DEFA14A · Filed: Mar 12, 2025 · CIK: 1653477
| Field | Detail |
|---|---|
| Company | Ingevity Corp (NGVT) |
| Form Type | DEFA14A |
| Filed Date | Mar 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, filing, corporate-governance
Related Tickers: INGV
TL;DR
INGV filed proxy docs on 3/12, looks like they named someone named M.
AI Summary
On March 12, 2025, Ingevity Corporation (INGV) filed a DEFA14A, indicating they issued a press release. The filing mentions Ingevity naming M. Ingevity Corporation is incorporated in Delaware and headquartered in North Charleston, SC.
Why It Matters
This filing is a proxy statement, which means it contains important information for shareholders regarding company decisions and voting matters.
Risk Assessment
Risk Level: low — This is a standard proxy filing (DEFA14A) and does not appear to contain unusual or high-risk information.
Key Players & Entities
- Ingevity Corporation (company) — Registrant
- M (person) — Newly named individual
- 4920 O'HEAR AVENUE (location) — Company Headquarters
- NORTH CHARLESTON, SC (location) — Company Headquarters
FAQ
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a Schedule 14A Proxy Statement filed with the SEC, used by companies to solicit proxy votes from shareholders for annual or special meetings.
When was this filing made?
This filing was made on March 12, 2025.
What specific event triggered this filing?
The filing indicates that on March 12, 2025, Ingevity Corporation issued a press release, and the filing is related to this event.
What is the company's primary business address?
The company's business address is 4920 O'HEAR AVENUE, SUITE 400, NORTH CHARLESTON, SC 29405.
What is the SEC file number for Ingevity Corporation?
The SEC file number for Ingevity Corporation is 001-37586.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 12, 2025 by M regarding Ingevity Corp (NGVT).